Advanced search
Publication Cover
Annals of Tropical Medicine & Parasitology Volume 102, 2008 - Issue sup1: Twenty Years of Mectizan Mass Treatment: Past, Present and Future Perspectives
Journal homepage
125
Views
36
CrossRef citations to date
0
Altmetric
Original Articles

The Mectizan Donation Program: 20 years of successful collaboration — a retrospective

B. ColatrellaGlobal Health Partnerships Merck & Co., Inc., 1 Merck Drive, P. O. Box 100, Whitehouse Station, NJ 08889-0100, U. S. A.
Pages 7-11 | Published online: 18 Jul 2013

References

  • Anon. (2002). Onchocerciasis Control Program nears Completion. Vienna: OPEC Fund for International Development.
  • Anon. (2006a). Public/private Partnerships in Global Health: Lessons from the Experiences of Merck & Co., Inc. Paper HMM (G) (06) INF8. London: Commonwealth Secretariat.
  • Anon. (2006b). APOC Strategic Action Matrix 2007-2015. Ouagadougou: African Programme for Onchocerciasis Control.
  • Benton B. (1998). Economic impact of onchocerciasis control through the African Programme for Onchocerciasis Control: an overview. Annals of Tropical Medicine and Parasitology, 92 (Suppl. 1), S33—S39.
  • Campbell, W. C. (1991). Ivermectin as an antiparasitic agent for use in humans. Annual Reviews of Microbiology, 45, 445–474.
  • Dull, B. H. (1990). Mectizan donation and the Mectizan Expert Committee. Acta Leielensia, 59, 399–403.
  • Dull, B. H. & Meredith, S. E. O. (1998). The Mectizan Donation Programme — a 10-year report. Annals of Tropical Medicine and Parasitology, 92 (Suppl. 1), S69—S71.
  • Foege, W. H. (1998). 10 years of Mectizan. Annals of Tropical Medicine and Parasitology, 92 (Suppl. 1), S7-S10.
  • Sturchio, J. L. (1992). The Decision to Donate Mectizan: Historical Background. Rahway, NJ: Merck & Co., Inc.
  • Taylor, H., Pacqué, M., Munoz, B. & Greene, B. M. (1990). Impact of mass treatment of onchocerciasis with ivermectin on the transmission of infection. Science, 250, 116–118.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.